HDAC4 Inhibitors as Antivascular Senescence Therapeutics.
Huang C, Lin Z, Liu X, Ding Q, Cai J, Zhang Z, Rose P, Zhu YZ.
Huang C, et al. Among authors: liu x.
Oxid Med Cell Longev. 2022 Jun 29;2022:3087916. doi: 10.1155/2022/3087916. eCollection 2022.
Oxid Med Cell Longev. 2022.
PMID: 35814270
Free PMC article.
Review.